HER2-Targeted Therapy Market Size, Share, Segment Analysis and Forecast 2027-2036
The global HER2-targeted therapy market centers on medicines that target human epidermal growth factor receptor 2 (HER2) in cancers with HER2 overexpression, amplification, or mutations. Demand comes from breast cancer, gastric cancer, and selected solid tumors. Antibody-drug conjugates, monoclonal antibodies, tyrosine kinase inhibitors, and bispecific antibodies define the treatment landscape. Market development through 2035 depends on clinical efficacy, treatment resistance, biomarker testing, combination regimens, manufacturing capabilities, and access to targeted medicines.
Last Updated : 26 October 2026
Category: Biotechnology
Insight Code: 7106
Format: PDF / PPT / Excel